|

Human Serum Albumin Infusion for LAT Group Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • The First Hospital of Jilin University1

Indications

  • Postoperative Hypoalbuminemia1
  • Postoperative Complications1
  • Gastric Cancer1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.